早期蒙特利尔认知评估预测卒中后长期认知与功能结局及死亡率
在德国和法国两项前瞻性医院队列研究的274例卒中患者中,于卒中后7天内进行蒙特利尔认知评估(MoCA)。基线MoCA评分<26分与3年随访期内认知障碍、功能受损及死亡率升高相关,且MoCA可提高预测认知和功能结局的曲线下面积。作者认为结果支持在卒中患者中常规使用MoCA。
要点
- 卒中后7天内MoCA评分<26分与长期认知障碍风险升高相关(OR 5.30,95%CI 2.75-10.22)。
- 该评分还与功能受损(mRS>2,OR 5.03,95%CI 2.20-11.51)和死亡率升高(HR 7.24,95%CI 1.99-26.35)相关。
- MoCA可提高预测认知障碍(AUC 0.81 vs 0.72,p=0.01)和功能受损(AUC 0.88 vs 0.84,p=0.047)的曲线下面积。
核心结论
- 早期MoCA认知测试可预测卒中后长期认知结局、功能结局和死亡率。
- 作者认为结果支持在卒中患者中常规使用MoCA。
研究设计与样本
- 研究为两项前瞻性医院队列研究,分别来自德国(n=125)和法国(n=149),共274例卒中患者。
- MoCA在卒中后7天内进行,认知和功能结局在卒中后6、12和36个月通过综合神经心理学测试、CDR量表、mRS和IADL评估。
- 采用广义估计方程分析,全因死亡率采用Cox比例风险模型,并调整人口学变量、教育、血管危险因素、病前认知状态和NIH卒中量表评分。
主要发现
- 汇总分析中,基线MoCA评分<26分与神经心理学测试定义的认知障碍相关(OR 5.30,95%CI 2.75-10.22)。
- 基线MoCA评分<26分与CDR评分≥0.5定义的认知障碍相关(OR 2.53,95%CI 1.53-4.18)。
- 基线MoCA评分<26分与mRS评分>2定义的功能受损相关(OR 5.03,95%CI 2.20-11.51),也与IADL评分<8定义的功能受损相关(OR 2.48,95%CI 1.40-4.38)。
- 基线MoCA评分<26分与3年随访期内死亡率升高相关(HR 7.24,95%CI 1.99-26.35)。
- MoCA评分<26分的患者在全部预设认知域(执行功能/注意力、记忆、语言、视空间能力)表现更差。
关键数值与推荐
- MoCA评分<26分作为认知障碍的阈值,与神经心理学测试定义的认知障碍OR 5.30(95%CI 2.75-10.22)相关。
- MoCA评分<26分与CDR评分≥0.5定义的认知障碍OR 2.53(95%CI 1.53-4.18)相关。
- MoCA评分<26分与mRS评分>2定义的功能受损OR 5.03(95%CI 2.20-11.51)相关。
- MoCA评分<26分与IADL评分<8定义的功能受损OR 2.48(95%CI 1.40-4.38)相关。
- MoCA评分<26分与死亡率HR 7.24(95%CI 1.99-26.35)相关。
临床怎么用
- 作者认为结果支持在卒中患者中常规使用MoCA进行早期认知测试。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether the Montreal Cognitive Assessment (MoCA) administered within 7 days after stroke predicts long-term cognitive impairment, functional impairment, and mortality. METHODS: MoCA was administered to 274 patients from 2 prospective hospital-based cohort studies in Germany (n = 125) and France (n = 149). Cognitive and functional outcomes were assessed at 6, 12, and 36 months after stroke by comprehensive neuropsychological testing, the Clinical Dementia Rating (CDR) scale, the modified Rankin Scale (mRS), and Instrumental Activities of Daily Living (IADL) and analyzed with generalized estimating equations. All-cause mortality was investigated by Cox proportional hazard models. Analyses were adjusted for demographic variables, education, vascular risk factors, premorbid cognitive status, and NIH Stroke Scale scores. The additive predictive value of MoCA was examined with receiver operating characteristic curves. RESULTS: In pooled analyses, a baseline MoCA score <26 was associated with cognitive impairment, defined by neuropsychological testing (odds ratio [OR] 5.30, 95% confidence interval [CI] 2.75-10.22) and by CDR score ≥0.5 (OR 2.53, 95% CI 1.53-4.18); functional impairment, defined by mRS score >2 (OR 5.03, 95% CI 2.20-11.51) and by IADL score <8 (OR 2.48, 95% CI 1.40-4.38); and mortality (hazard ratio 7.24, 95% CI 1.99-26.35) across the 3-year follow-up. Patients with MoCA score <26 performed worse across all prespecified cognitive domains (executive function/attention, memory, language, visuospatial ability). MoCA increased the area under the curve for predicting cognitive impairment (neuropsychological testing 0.81 vs 0.72, p = 0.01) and functional impairment (mRS score >2, 0.88 vs 0.84, p = 0.047). CONCLUSION: Early cognitive testing by MoCA predicts long-term cognitive outcome, functional outcome, and mortality after stroke. Our results support routine use of the MoCA in stroke patients.
引用
- Zietemann V, Georgakis MK, Dondaine T, et al. Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke. Neurology. 2018. PMID: 30333158. doi:10.1212/WNL.0000000000006506
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。